ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lun…

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
Forbes

Another Approach To Checkpoint Inhibitors: Targeting Receptors

Checkpoint inhibitors are antibody-based cancer therapies that unlock the immune system’s natural ability to fight cancer. These treatments work by blocking special proteins called immune checkpoints, ...

Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® In Combination with Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Forbes

How Cancer Immunotherapy Checkpoint Inhibitors Work

Skin cancers, lung cancers, lymphomas—though these cancers affect different parts of the body, they can all be treated with one of the latest therapies medicine has to offer: checkpoint inhibitors.
Frontiers

Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy

Cancer represents a key challenge in medical science, manifesting as a disease where the immune system fails to recognize and eliminate tumor cells. The phenomenon of immune evasion by cancer cells ...

Gut bacteria molecule boosts lung cancer treatment response

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the ...
Targeted Oncology

Nogapendekin Alfa Inbakicept Shows Promise in Checkpoint-Refractory NSCLC

QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, ...

Sugar structures on kidney cells predict immune therapy response, study finds

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These antibodies activate the immune system and enable T cells to detect and destroy ...
The American Journal of Managed Care

Data Highlights Factors Impacting Immune Checkpoint Inhibitors in mCRC

MSI-H mCRC patients receiving ICIs had significantly improved OS compared to chemotherapy, with a 63% improvement in survival. MSS patients with high albumin levels or recent antibiotic use also ...
Healio

Immune checkpoint inhibitor therapy doubles psoriasis risk

Please provide your email address to receive an email when new articles are posted on . Patients who received PD-1 or PD-L1 agents exhibited increased risk for psoriasis. Medical professionals should ...
Labroots

Complete Cancer Protein Inhibition Improves Anti-Tumor Immunity

The concept of immunotherapy or boosting the body’s immune system to target tumors was first practically applied in the early ...
Medscape

Checkpoint Inhibitor Prices Dropped Marginally Over Decade

A recent study found that monthly prices of checkpoint inhibitors decreased only slightly from 2015 to 2024, with declines in annual average sales prices ranging from 0.21% to 4.85%. Checkpoint ...